Your original comment painted it as a China moat against US/EU labs. Completely different from instead being a unique disadvantage to EU labs by which the US labs, among others, aren't really affected.
Europe gets barely any funding because it is so far behind and cannot use the illegal strategies Chinese labs use to distill Opus/Astra. Mistral cannot compete because the competition is literally breaking every law.